Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Interaction of Diazosulfanilic Acid and the Opiate Receptor

Inhibition of Specific Binding to Synaptic Membranes and Labeling of a Membrane Lipid Stereospecifically Protected by Opioids

P. Y. LAW, T. J. OSTWALD, E. L. WAY and H. H. LOH
Molecular Pharmacology May 1981, 19 (3) 355-366;
P. Y. LAW
Departments of Pharmacology and Psychiatry and Langley Porter Psychiatric Institute, University of California, San Francisco, San Francisco, California 94143
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. J. OSTWALD
Departments of Pharmacology and Psychiatry and Langley Porter Psychiatric Institute, University of California, San Francisco, San Francisco, California 94143
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. L. WAY
Departments of Pharmacology and Psychiatry and Langley Porter Psychiatric Institute, University of California, San Francisco, San Francisco, California 94143
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. H. LOH
Departments of Pharmacology and Psychiatry and Langley Porter Psychiatric Institute, University of California, San Francisco, San Francisco, California 94143
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

3,5-Diiodo-4-diazosulfanilic acid (DIDSA) inhibited the opiate specific binding to the rat brain synaptic membrane. DIDSA inhibited [3H]dihydromorphine binding more rapidly and to a greater extent than [3H]naloxone binding. That the inhibition of the opiate binding resulted from the derivatization of the opiate receptor sites by DIDSA was demonstrated by Scatchard analysis of the binding data and by the ability of 0.1 µM concentrations of various opiate ligands and not 0.1 µM dextrorphan to attenuate the DIDSA inhibition. DIDSA was probably reacting with a population of sites distinct from those which reacted with N-ethylmaleimide (NEM). This was demonstrated by the ability of 100 mM Na+ to decrease NEM inhibition of [3H]naloxone binding and not that of DIDSA inhibition. The difference in NEM and DIDSA reactive sites was further demonstrated by the ability of hypoosmotic lysis of synaptosomes to enhance DIDSA but not NEM inhibition of naloxone binding. When synaptic membranes were derivatized with a combination of 0.4 mM, DIDSA and 0.1 mM NEM in the presence of levorphanol and subsequently labeled with [125I]diazosulfanilic acid (DISA), there was a levorphanol concentration-dependent increase in radioactivity incorporated into the chloroform:methanol (2:1) extractable membrane lipids previously protected from the reagents with levorphanol but not those lipids protected with dextrorphan. There was a parallel increase in the amount of opiate receptor binding activity protected by the levorphanol. Moreover, the 2-fold increase in the radiolabeling of the protected membrane polar lipids could be eliminated by the addition of 0.1 µM levorphanol but not by the addition of dextrorphan in the reaction mixtures containing [125I]DISA. The identity of the polar lipid selectively protected by levorphanol was determined by thin-layer chromatography in silica gel G plates in three different solvent mixtures. The chromatographic patterns of the membrane polar lipids extract in these solvent mixtures compared favorably with those of the standard phosphatidylethanolamine. Separation of membranous protein with Sephadex column chromatography and polyacrylamide gel isoelectric focusing did not resolve any proteins which were significantly protected by levorphanol.

ACKNOWLEDGMENT The authors wish to thank Ms. K. Welch for her untiring efforts in the preparation of the manuscript.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 19, Issue 3
1 May 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interaction of Diazosulfanilic Acid and the Opiate Receptor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Interaction of Diazosulfanilic Acid and the Opiate Receptor

P. Y. LAW, T. J. OSTWALD, E. L. WAY and H. H. LOH
Molecular Pharmacology May 1, 1981, 19 (3) 355-366;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Interaction of Diazosulfanilic Acid and the Opiate Receptor

P. Y. LAW, T. J. OSTWALD, E. L. WAY and H. H. LOH
Molecular Pharmacology May 1, 1981, 19 (3) 355-366;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Anti-aromatase activity of exemestane phase II metabolites
  • α-Conotoxin Binding Site on the GABAB Receptor
  • Upacicalcet binds to the amino acid binding site of CaSR
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics